CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

Area of Science:

• Cell biology
• Gene editing
• Stem cell research

Background:

• Conventional methods for generating induced pluripotent stem cells (iPSCs) involve ectopic transcription factor expression, which can cause off-target effects and cellular heterogeneity.
• CRISPR activation (CRISPRa) presents an alternative by activating endogenous pluripotency genes, potentially leading to more uniform reprogramming.

Purpose of the Study:

• To develop and evaluate an optimized CRISPRa system for high-efficiency and high-quality reprogramming of human somatic cells into iPSCs.
• To compare the reprogramming efficiency and specificity of optimized CRISPRa against conventional methods.

Main Methods:

• Utilized CRISPR activation (CRISPRa) technology for reprogramming.
• Optimized CRISPRa by additionally targeting the embryo genome activation-enriched Alu-motif and the miR-302/367 locus.
• Employed single-cell transcriptome analysis to assess reprogramming outcomes.

Main Results:

• Achieved high-efficiency reprogramming of human somatic cells into iPSCs using the optimized CRISPRa system.
• Demonstrated that efficient reprogramming depended on targeting specific genomic loci (Alu-motif and miR-302/367).
• Single-cell transcriptome data indicated that optimized CRISPRa facilitated a more direct and specific transition to pluripotency compared to conventional reprogramming.

Conclusions:

• Optimized CRISPRa is a powerful tool for efficient and high-quality reprogramming of human cells into iPSCs.
• This approach minimizes cellular heterogeneity often associated with traditional reprogramming techniques.
• The findings support the broader application of CRISPRa in regenerative medicine and stem cell biology.